Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2008 2
2009 1
2010 3
2011 1
2012 1
2013 1
2014 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
[An unresolved question].
Espinàs J, Vilaseca J, Castro JA, Ibáñez F, Lorenzo A, Alonso R, Corredera A, Daza P, Eirea C, Fluixá C, García G, González MJ, Martín-Carrillo P, Martínez M, Olmos O, Pérez JC, Puig B, Ramos D, Sempere G; Comité Editorial de la Guía Práctica de la Salud, semFYC. Espinàs J, et al. Among authors: fluixa c. Aten Primaria. 2006 Feb 15;37(2):67-8. doi: 10.1157/13084487. Aten Primaria. 2006. PMID: 16527110 Free PMC article. Spanish. No abstract available.
Impact of the COVID-19 Pandemic on a Cancer Fast-Track Programme.
Martínez MT, Moragon S, Ortega-Morillo B, Montón-Bueno J, Simon S, Roselló S, Insa A, Viala A, Navarro J, Sanmartín A, Fluixá C, Julve A, Soriano D, Buch E, Peña A, Franco J, Martínez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Bermejo B, Cervantes A, Chirivella Gonzalez I. Martínez MT, et al. Among authors: fluixa c. Cancer Control. 2022 Jan-Dec;29:10732748221131000. doi: 10.1177/10732748221131000. Cancer Control. 2022. PMID: 36355430 Free PMC article.
[The need to select drugs: the responsibility of choosing].
Vilaseca Canals J, Espinàs Boquet J, Fluixá Carrascosa C, Diogène Fadini E, Rodríguez Cumplido D, Asensio Ostos C; miembros del Comité Editorial de la Guía Terapéutica en Atención Primaria Basada en la Selección Razonada del Medicamento (semFYC). Vilaseca Canals J, et al. Aten Primaria. 2009 Dec;41(12):657-8. doi: 10.1016/j.aprim.2009.09.003. Epub 2009 Oct 14. Aten Primaria. 2009. PMID: 19828213 Free PMC article. Spanish. No abstract available.
[Therapeutic guide to primary care based on the evidence, 2nd edition: an honest and practical work].
Vilaseca J, Espinàs J, Fluixà C, Ibáñez F, Alonso R, Castro JA, Corredera A, Daza P, de la Figuera E, Eirea C, García G, González MJ, Lorenzo A, Martín-Carrillo P, Martínez M, Olmos O, Pérez JC, Puig B, Ramos D, Rodríguez JC, Sempere G, Diogène E, Rodríguez D. Vilaseca J, et al. Among authors: fluixa c. Aten Primaria. 2004 Dec;34(10):515-7. doi: 10.1016/s0212-6567(04)70854-9. Aten Primaria. 2004. PMID: 15607051 Free PMC article. Spanish. No abstract available.
Appropriateness of clopidogrel use according to current recommendations.
Fornós-Garrigós A, Orozco-Beltrán D, Gil-Guillén VF, Puig-Barberà J, Fluixa C, Fernández A. Fornós-Garrigós A, et al. Among authors: fluixa c. Fam Pract. 2014 Dec;31(6):694-8. doi: 10.1093/fampra/cmu039. Epub 2014 Aug 11. Fam Pract. 2014. PMID: 25114161
[Promotion of research in primary care].
Grupo de trabajo para la Promoción de la Investigación en Atención Primaria de la Comunidad Valenciana. Grupo de trabajo para la Promoción de la Investigación en Atención Primaria de la Comunidad Valenciana. Aten Primaria. 2008 Mar;40(3):125-31. doi: 10.1157/13116627. Aten Primaria. 2008. PMID: 18373924 Free PMC article. Spanish.
Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Sanfélix-Genovés J, Sanfélix-Gimeno G, Peiró S, Hurtado I, Fluixà C, Fuertes A, Campos JC, Giner V, Baixauli C. Sanfélix-Genovés J, et al. Among authors: fluixa c. Osteoporos Int. 2013 Mar;24(3):1045-55. doi: 10.1007/s00198-012-2018-6. Epub 2012 May 23. Osteoporos Int. 2013. PMID: 22618269
Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia.
Gil-Guillen V, Orozco-Beltran D, Redon J, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fluixa C, Fernandez A, Martin-Moreno JM, Pascual-de-la-Torre M, Trillo JL, Durazo-Arvizu R, Cooper R, Hermenegildo M, Rosado L. Gil-Guillen V, et al. Among authors: fluixa c. BMC Public Health. 2010 Nov 22;10:717. doi: 10.1186/1471-2458-10-717. BMC Public Health. 2010. PMID: 21092179 Free PMC article.
Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study.
Brotons C, Soriano N, Moral I, Rodrigo MP, Kloppe P, Rodríguez AI, González ML, Ariño D, Orozco D, Buitrago F, Pepió JM, Borrás I; PREseAP study research team. Brotons C, et al. Rev Esp Cardiol. 2011 Jan;64(1):13-20. doi: 10.1016/j.recesp.2010.07.005. Epub 2010 Dec 30. Rev Esp Cardiol. 2011. PMID: 21194823 Free article. Clinical Trial.
11 results